|
|
|
|
|
|
|
|
|
|
Ind-Swift Laboratories Ltd.
|
|
|
|
|
|
|
|
|
BSE Code |
532305
|
|
ISIN Demat |
INE915B01019
|
|
Book Value (Rs) |
94.72
|
|
|
NSE Code |
INDSWFTLAB
|
|
Dividend Yield % |
0.00
|
|
Market Cap(Rs Mn) |
6848.17
|
|
|
TTM PE(x) |
18.07
|
|
TTM EPS(Rs) |
6.41
|
|
Face Value (Rs) |
10
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
Incorporation Year
|
04-01 1995
|
|
Registered Office
|
S C O 850,Shivalik Enclave, N A C,Manimajra, Chandigarh,
Union Territory-160101 .
|
|
ISINNO
|
INE915B01019
|
|
Phone
|
0172 5061850 / 2730920
|
|
E-mail
|
investor@indswiftlabs.com |
|
URL
|
www.indswiftlabs.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
N R Munjal
|
|
Managing Director
|
N R Munjal
|
|
Company Secretary
|
Pardeep Verma
|
|
Listing
|
BSE,NSE,MCX
|
|
|
|
|